Study protocol for WHO and UNICEF estimates of global, regional, and national preterm birth rates for 2010 to 2019

Abstract

Background Preterm birth is a leading cause of death among children under five years. Previous estimates indicated global preterm birth rate of 10.6% (14.8 million neonates) in 2014. We aim to update preterm birth estimates at global, regional, and national levels for the period 2010 to 2019. Methods Preterm birth is defined as a live birth occurring before 37 completed gestational weeks, or <259 days since a woman’s last menstrual period. National administrative data sources for WHO Member States with facility birth rates of ≥80% in the most recent year for which data is available will be searched. Administrative data identified for these countries will be considered if ≥80% of UN estimated live births include gestational age information to define preterm birth. For countries without eligible administrative data, a systematic review of studies will be conducted. Research studies will be eligible if the reported outcome is derived from an observational or intervention study conducted at national or sub-national level in population- or facility-based settings. Risk of bias assessments will focus on gestational age measurement method and coverage, and inclusion of special subgroups in published estimates. Covariates for inclusion will be selected a priori based on a conceptual framework of plausible associations with preterm birth, data availability, and quality of covariate data across many countries and years. Global, regional and national preterm birth rates will be estimated using a Bayesian multilevel-mixed regression model. Discussion Accurate measurement of preterm birth is challenging in many countries given incomplete or unavailable data from national administrative sources, compounded by limited gestational age assessment during pregnancy to define preterm birth. Up-to-date modelled estimates will be an important resource to measure the global burden of preterm birth and to inform policies and programs especially in settings with a high burden of neonatal mortality. Trial registration PROSPERO registration: CRD42021237861.

Prevalence, predictors of low birth weight and its association with maternal iron status using serum ferritin concentration in rural Eastern Ethiopia: a prospective cohort study

“…For this specific paper, 427 whose serum ferritin and hemoglobin concentrations were determined at their second or third trimester during the baseline survey were considered. Of 427 followed pregnant women, birth weight was taken from 412 neonates, as lost to follow-up [ 2 ], multiple births [ 3 ] and early neonatal death [ 2 ], birth weight measurement taken after 72 h of birth [ 3 ], and fetal loss [ 5 ] were excluded. We recruited participants selected from the HDS-HRC database voluntarily from the community during home-to-home visits.…”

“…Moreover,​macro-and micro-nutrient requirements rise during pregnancy to provide for physiological and metabolic changes and fetal development [ 1 ]. World Health Organization (WHO) defined LBW as the weight of a neonate below 2500 g at birth, irrespective of the gestational age of the neonate [ 2 , 3 ]. Worldwide, low birth weight (LBW) remains an important public health concern [ 2 ].…”

Editorial: Reproduction and the Inflammatory Response

“…Even amongst those couples able to initiate pregnancy, challenges are still faced. Embryo loss between fertilization and birth is estimated between 40-60% (3), while pregnancy complications, including preeclampsia (PE, 2-8% of pregnancies) and preterm birth (10.6% of births), are the leading cause of death amongst women of reproductive years (4,5). Gynecological conditions, such as endometriosis (10%) (6), polycystic ovary syndrome (PCOS, 5-20%) are common (7), in addition to sexually transmitted infections (Chlamydia, 2016 = 127 million estimated infections) (8) and parental lifestyle factors not only influence fertility but also lead to adverse birth outcomes and lay the foundations for offspring susceptibility to disease (9).…”

Decreased plasma levels of PDGF-BB, VEGF-A, and HIF-2α in preterm infants after ibuprofen treatment

“…With the increasing survival of extremely preterm infants, the incidence of severe morbidities in survivors attracted significant attention (1)(2)(3)(4). In these tiny infants, the natural closure rate of patent ductus arteriosus (PDA) is only 10-20% in the early of life (5,6).…”